Article -> Article Details
| Title | India Continuous Glucose Monitoring Devices Market Share, Trends, Growth, Outlook and Report by 2034 |
|---|---|
| Category | Sciences --> Technology |
| Meta Keywords | India Continuous Glucose Monitoring Devices |
| Owner | SAKSHI BAHANDARI |
| Description | |
| According to IMARC Group's report titled "India
Continuous Glucose Monitoring Devices Market Report: Size, Share, Trends and Forecast
by Component, Demographics, End User, and Region, 2026-2034", the
report offers a comprehensive analysis of the industry, including India
continuous glucose monitoring devices market share, trends, growth and regional
insights.
How Big is the India Continuous Glucose Monitoring
Devices Industry ? The India continuous glucose monitoring devices market size was valued at USD
240.6 Million in 2025 and is projected to grow to USD 359.41
Million by 2034, with an expected compound annual growth rate (CAGR)
of 4.56% from 2026 to 2034. India Continuous Glucose Monitoring Devices Market
Trends: The India Continuous Glucose Monitoring (CGM) Devices Market
is currently witnessing a sophisticated structural shift, dominated by the
aggressive integration of digital health ecosystems and AI-driven
analytics. No longer satisfied with periodic finger-stick testing,
patients—particularly those with Type 1 and advanced Type 2 diabetes—are
increasingly adopting real-time CGM systems that offer continuous
data streams and predictive alerts for hypoglycemia and hyperglycemia. This "flight
to connectivity" has triggered a massive demand for devices that are not
only accurate but also seamlessly integrated with smartphones, prompting
manufacturers to prioritize Bluetooth-enabled sensors and cloud-based
data sharing platforms. Additionally, the post-pandemic healthcare landscape
has permanently altered disease management strategies, with remote patient
monitoring evolving from a niche service into a core requirement for
chronic care. Companies are now adopting "connected care"
models, utilizing CGM data to enable physicians to monitor patients remotely
and adjust treatment plans in real-time, reducing the need for physical
consultations. Moreover, there is a distinct trend of democratization where CGM
technology is spilling beyond premium healthcare segments to the broader middle
class. Emerging initiatives like the "Make in
India" campaign are driving local manufacturing, which is expected to
lower device costs and surge absorption in Tier-2 and Tier-3 cities. This
modernization of the diabetes care ecosystem is forcing a redesign of
traditional monitoring tools into user-friendly, minimally invasive wearable
technologies that prioritize patient comfort and long-term adherence. Request Free Sample Report : https://www.imarcgroup.com/india-continuous-glucose-monitoring-devices-market/requestsample India Continuous Glucose Monitoring Devices Market Scope
and Growth Analysis: The robust and sustained expansion of the India Continuous
Glucose Monitoring Devices Market is fundamentally anchored by the country’s
alarming rise in diabetes prevalence and the government’s push for digital
health adoption. The operationalization of the Ayushman Bharat
Digital Mission (ABDM) has unlocked new avenues for integrating health
data, making it viable for digital health platforms to incorporate CGM readings
into electronic medical records. In addition, the maturation of
the wearable technology sector has acted as a critical financial
catalyst, democratizing access to health monitoring tools. The success of
smartwatches and fitness trackers has significantly boosted consumer awareness,
instilling deep confidence among patients who are now transitioning to
dedicated medical-grade CGM devices for more precise glycemic control. Furthermore, the rapid urbanization of the population is
creating a parallel boom in specialized home healthcare assets. There is
an explosive demand for sensors and transmitters, driven by the
growing preference for managing diabetes at home rather than in clinical
settings. This diversification is further supported by advancements in
sensor technology, such as extended wear duration and factory calibration,
which have streamlined the user experience, creating a risk-mitigated environment
that ensures a steady supply of reliable monitoring solutions to meet the
soaring demand from a health-conscious diabetic population. Explore the Full Report with Charts, Table of Contents,
and List of Figures: https://www.imarcgroup.com/india-continuous-glucose-monitoring-devices-market India Continuous Glucose Monitoring Devices Market
Segmentation: The market report offers a comprehensive analysis of the
segments, highlighting those with the largest India continuous glucose
monitoring devices market share. It includes forecasts for the period
2026-2034 and historical data from 2020-2025 for the following segments. Component Insights:
Regional Insights:
Competitive Landscape: The report offers an in-depth examination of the competitive
landscape. It includes a thorough competitive analysis encompassing market
structure, key player positioning, leading strategies for success, a
competitive dashboard, and a company evaluation quadrant. Ask Analyst For Customization: https://www.imarcgroup.com/request?type=report&id=43726&flag=C Other Key Points Covered in the Report:
If you need specific information that is not currently
within the scope of the report, we will provide it to you as a part of the
customization. About Us: IMARC Group is a global management consulting firm that
helps the world’s most ambitious changemakers to create a lasting impact. The
company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment,
feasibility studies, company incorporation assistance, factory setup support,
regulatory approvals and licensing navigation, branding, marketing and sales
strategies, competitive landscape and benchmarking analyses, pricing and cost
research, and procurement research. Contact Us: IMARC Group 134 N 4th St. Brooklyn, NY 11249, USA Email: sales@imarcgroup.com Tel No:(D) +91 120 433 0800 United States: +1-201971-6302 | |
